nach oben

Erschienen in:

20.05.2020 | main topic

COVID-19: a primer for healthcare providers

verfasst von: Donna M. Bearden, MD, MPH, Patricia B. Aiken, MD, Yu Hsin Cheng, MD, Emily Mai, MD, Timothy M. Peters, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 13-14/2020

Einloggen, um Zugang zu erhalten

Summary

According to the World Health Organization (WHO) the China office was first notified of cases of atypical pneumonia in Wuhan City on 31 December 2019. A viral genome sequence of a novel coronavirus, currently termed SARS-CoV‑2, with a disease process called COVID-19 was released 1 week later via online resources to obtain public health support in control of spread. Since then, the virus rapidly evolved into a global pandemic. Therefore, healthcare providers need to be familiar with the clinical presentation of infected patients and measures to quickly isolate them. The prevention of nosocomial spread is paramount to proper control of COVID-19 and is reviewed. Currently, treatment is supportive. Researchers are working to develop vaccines and identify effective antiviral interventions. Those recently discussed in the literature are briefly reviewed.

Vorheriger Artikel COVID-19 versus seasonal influenza 2019–2020: USA

Nächster Artikel Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring province of Wuhan, China

Pillaiyar T, Meenakshisundaram S, Manickam. Recent discovery and development of inhibitors targeting corona viruses. Drug Discov Today. 2020; https://doi.org/10.1016/j.drudis.2020.01.015.CrossRefPubMedPubMedCentral

Paules C, Marston H, Fauci A. Corona virus infections—more than Just the common cold. JAMA. 2020; https://doi.org/10.1001/jama.2020.0757.CrossRefPubMed

Sheahan T, Sims A, Leist S. Comparative therapeutic efficacy of remdesivir and combination lopinavir,ritonavir, and interferon beta against MERS-CoV. Nat Comm. 2020; https://doi.org/10.1038/s41467-019-13940-6/www.nature.com/nature.CrossRef

WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). 2018. https://www.who.intemergencies/mers-cov/en/. Accessed 21 Feb 2020.

Cho J, Kang J, Ha Y, et al. MERS-CoV outbreak following a single patient exposure in an emergency department in South Korea: an epidemiological outbreak study. Lancet. 2016;388:994–1001.CrossRef

Wang M, Coa R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; https://doi.org/10.1038/s41422-020-0282-0.CrossRefPubMedPubMedCentral

Zhao S, Zhaung Z, Ran J, et al. The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data driven correlation report. Travel Med Infect Dis. 2020; https://doi.org/10.1016/j.tmaid.2020.101568.CrossRefPubMedPubMedCentral

Qun L, Xuhua G, Peng W, et al. Early transmission dynamics in Wuhan, China of novel corona-infected pneumonia. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2001316.CrossRef

Routh C, Shunk M, Sothmann P. Transmission of 2019-ncoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; https://doi.org/10.1056/NEJMc2001468.CrossRef

10.

Holshue M, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the Unites States. N Engl J Med. 2020; https://doi.org/10.1056/NEJMoa2001191.CrossRefPubMedPubMedCentral

11.

Chen Z, Fu J, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Ped. 2020; https://doi.org/10.1007/s12519-020-00345-5.CrossRef

12.

Nanshan C, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel corona virus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; https://doi.org/10.1016/S0140-6736(20)30211-7.CrossRef

13.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; https://doi.org/10.1016/S0140-6736(20)30183-5.CrossRefPubMedPubMedCentral

14.

Chung M, Bernheim A, Mei X. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020; https://doi.org/10.1148/radiol.2020200230.CrossRefPubMedPubMedCentral

15.

Pan Y, Guan H. Imaging changes in patients with 2019-nCoV. Eur Rad. 2020; https://doi.org/10.1007/s00330-020-06713-z.CrossRef

16.

Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with Coronavirus Disease 2019 pneumonia in Wuhan, China. JAMA Int Med. 2020; https://doi.org/10.1001/jaminternalmed.2020.0994.CrossRef

17.

Mao L, Jin H, Hu Y, et al. Neurological manifestations of hospitalized patients with Coronacirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020; https://doi.org/10.1001/jamaneurol.2020.1127.CrossRefPubMedPubMedCentral

18.

Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020; https://doi.org/10.1056/NEJMc2007575.CrossRefPubMedPubMedCentral

19.

Inciardi R, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; https://doi.org/10.1001/jamacardio.2020.1096.CrossRefPubMed

20.

Wax R, Christian M. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019nCoV) patients. Can J Anesth. 2020; https://doi.org/10.1007/s12630-020-01591-x.CrossRefPubMed

21.

McDonald L, Simor A, Su I, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis. 2004;10:777–81.CrossRef

22.

XINHUANET. Novel coronavirus may spread via digestive system: experts. English.news.cn. 2020. http://www.xinhuanet.com/english/2020-02/02/c_138749620.htm. Accessed 18 Feb 2020.

23.

Government of Canada. Interim national case definition: novel coronavirus (2019-nCoV). 2020. https://www.canada.ca/enpublic-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/interim-guidance-acute-healthcare-settings.htm. Accessed 23 Feb 2019.

24.

Nowak J, Walkowiak. Is lithium a potential treatment for the novel Wuhan (2019-nCoV) coronavirus? A scoping review. F1000Res. 2020;9:93. https://doi.org/10.12688/f1000research.22299.1.CrossRefPubMedPubMedCentral

25.

Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020; https://doi.org/10.5582/bst.2020.01020.CrossRefPubMed

26.

Sanders J, Monogue M, Jodlowski T, et al. Pharmacologic treatments for Coronavirus disease 2019 (COVID-19) A review. JAMA. 2020; https://doi.org/10.1001/jama2020.6019.CrossRefPubMed

Titel: COVID-19: a primer for healthcare providers
verfasst von: Donna M. Bearden, MD, MPH
Patricia B. Aiken, MD
Yu Hsin Cheng, MD
Emily Mai, MD
Timothy M. Peters, MD
Publikationsdatum: 20.05.2020
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 13-14/2020
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-020-01678-x

Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria

main topic

MUW researcher of the month

MUW researcher of the month

Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring province of Wuhan, China

main topic

Obituary for Christian Kunz, 1927–2020

obituary

The start of the Austrian response to the COVID-19 crisis: a personal account

Open Access
main topic

Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020)

Open Access
main topic

Springer Medizin Österreich

COVID-19: a primer for healthcare providers

Summary

Weitere Artikel der Ausgabe 13-14/2020

Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria

MUW researcher of the month

Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring province of Wuhan, China

Obituary for Christian Kunz, 1927–2020

The start of the Austrian response to the COVID-19 crisis: a personal account

Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020)

Springer Medizin Österreich

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Regional differences in hospital admissions for ST-elevation and non-ST-elevation myocardial infarctions during the Coronavirus disease-19 (COVID-19) pandemic in Austria

MUW researcher of the month

Effect of a bundle of intervention strategies for the control of COVID-19 in Henan, a neighboring province of Wuhan, China

Obituary for Christian Kunz, 1927–2020

The start of the Austrian response to the COVID-19 crisis: a personal account

Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020)